Investing Profile

Colleen Cuffaro

VCInvestor

Partner at Canaan Partners

Your Intro Paths to Colleen Cuffaro

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Colleen is a member of

University of Pennsylvania Network

144 CONNECTIONS

Canaan Partners Network

15 CONNECTIONS

Find Colleen Cuffaro on

Current Investing Position

Investment Range

$250K - $20.0M

Sweet Spot

$10.0M

Investments On Record

Current Fund Size

$800M

Colleen Cuffaro is on these Sector & Stage Rankings

Colleen Cuffaro's Investments On Record (6)

Company	StageDateRound Size	Total Raised
CatalYm	Series DJul 2024$150M	$200M
Co-investors: Marianne Uteng (Novartis Venture Fund), Oscar Slotboom (BGV (BioGeneration Ventures)), Jonathan Tobin (Brandon Capital Partners), Nathalie Weitemeyer (Bayern Kapital), Rogier Rooswinkel (Forbion), Jon Edwards (Red Tree Venture Capital)
AgomAb Therapeutics	Series COct 2023$100M	$200M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital)
Comet Therapeutics	Series AJun 2019$29M	$29M
Co-investors: Roel Bulthuis (INKEF Capital), Henrijette Richter (Soffinova Partners)
Arrakis Therapeutics	Series BApr 2019$75M Series AFeb 2017$38M	$110M
Co-investors: Richard Gaster (venBio), Jakob Loven (Nextech Invest)
NextCure	Series BNov 2018$93M Series AJan 2016$67M	$160M
Co-investors: Tim Shannon (Canaan Partners), David Kabakoff (HealthQuest Capital)
Arvinas	Series CApr 2018$55M Series BOct 2015$42M Series ASep 2013$15M	$140M
Co-investors: Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Tim Shannon (Canaan Partners), Liam Ratcliffe (Access Biotechnology), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest), Daniel Wagner (Connecticut Innovations), Martin Alexander Gershon (Endeavor Venture Funds)